Evidence map›Paper›PMID 35876116›Full record

ReviewDrug metabolism reviews2022

Bioactivation and reactivity research advances - 2021 year in review.

Klarissa D Jackson, Upendra A Argikar, Sungjoon Cho, Rachel D Crouch, James P Driscoll, Carley J S Heck, Lloyd King, Hlaing Holly Maw, Grover P Miller, Herana Kamal Seneviratne and 4 more

Abstract readReview
In one paragraph

Review in Drug metabolism reviews, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Klarissa D JacksonDivision of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, Chapel Hill, NC, USA.ORCID 0000-0002-9388-9800
Upendra A ArgikarNon-Clinical Development, Bill & Melinda Gates Medical Research Institute, Cambridge, MA, USA.ORCID 0000-0002-0939-0813
Sungjoon ChoDepartment of Drug Metabolism and Pharmacokinetics, Genentech, Inc., South San Francisco, CA, USA.ORCID 0000-0003-1215-9759
Rachel D CrouchDepartment of Pharmaceutical Sciences, Lipscomb University College of Pharmacy and Health Sciences, Nashville, TN, USA.ORCID 0000-0002-4525-6072
James P DriscollDepartment of Drug Metabolism and Pharmacokinetics, Bristol Myers Squibb, Brisbane, CA, USA.ORCID 0000-0002-3736-1673
Carley J S HeckMedicine Design, Pfizer Worldwide Research, Development and Medical, Groton, CT, USA.ORCID 0000-0002-6842-3670
Lloyd KingDepartment of DMPK, UCB Biopharma UK, Slough, UK.ORCID 0000-0002-3301-7533
Hlaing Holly MawDrug Metabolism and Pharmacokinetics, Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT, USA.ORCID 0000-0002-4051-7958
Grover P MillerDepartment of Biochemistry and Molecular Biology, University of Arkansas for Medical Sciences, Little Rock, AR, USA.ORCID 0000-0002-4743-8187
Herana Kamal SeneviratneDepartment of Pharmacology and Molecular Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA.ORCID 0000-0002-7221-7060
Shuai WangDepartment of Drug Metabolism and Pharmacokinetics, Genentech, Inc., South San Francisco, CA, USA.ORCID 0000-0002-3282-1343
Cong WeiDrug Metabolism & Pharmacokinetics, Biogen Inc., Cambridge, MA, USA.ORCID 0000-0003-2310-9255
Donglu ZhangDepartment of Drug Metabolism and Pharmacokinetics, Genentech, Inc., South San Francisco, CA, USA.ORCID 0000-0001-8677-9737
S Cyrus KhojastehDepartment of Drug Metabolism and Pharmacokinetics, Genentech, Inc., South San Francisco, CA, USA.ORCID 0000-0002-8385-9288

Funding

Interindividual Variability in Drug Metabolism in Representative PopulationsR35GM143044 · NIGMS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Klarissa D. Jackson · 2021 to 2026
$2.3M
NIGMS NIH HHS R35 GM143044
6 · The paper itself

Abstract

This year's review on bioactivation and reactivity began as a part of the annual review on biotransformation and bioactivation led by Cyrus Khojasteh (see references). Increased contributions from experts in the field led to the development of a stand alone edition for the first time this year focused specifically on bioactivation and reactivity. Our objective for this review is to highlight and share articles which we deem influential and significant regarding the development of covalent inhibitors, mechanisms of reactive metabolite formation, enzyme inactivation, and drug safety. Based on the selected articles, we created two sections: (1) reactivity and enzyme inactivation, and (2) bioactivation mechanisms and safety (Table 1). Several biotransformation experts have contributed to this effort from academic and industry settings.[Table: see text].

Indexed as

Microsomes, LiverBiotransformationHumans

Identifiers

PMID35876116
PMCPMC10282953

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.